to 28% 2016 2017 % change million Baht million Baht y-on-y Sales and service income 27,747 31,482 13.5% EBITDA 7,494 8,725 16.4% Net profit 2,316 3,594 55.2% Normalized net profit (NNP)* 2,090 2,918

, change in regulation for retirement provisioning). As a result after a very successful 2018 with over 24% topline and 30% EBITDA growth, this year has witnessed a 13% revenue and 28% consolidate EBITDA

วันที่ 15 ตุลาคม 2545 1 NO. (SUTHA-SET) 016/2019/EN 14 August 2019 Subject : Clarification of Q2/2019 the total revenues and the Net profit change more than 20% To : The President of the Stock

. The main reasons were an increase in staff expense and doctor fee as a result of operational preparation for the expansion of the new hospital and the opening of the new specialized centers in the

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

contract from several financial institutions. A summary of the key operational matters and events for the 2nd Quarter 2017 GFPT recorded decent performance for its operations in 2Q2017. GFPT Group had total

: “Sales wise we had a very good third quarter buoyed by a strong market and good operational performance where we were able to run all available assets at full capacity including in our recently acquired

that the operating results will improve in early 2021. As of now, the company is open for business as per usual, no direct operational impact from the COVID-19 outbreak situation. 2. Operating Results

commercially operational due to the appreciation of the Baht against the U.S. dollar when actual payment was made. 2.4) Finance cost and tax 6M'2016 6M'2017 % change million Baht million Baht % Finance cost

Operating Results of the Company in Q2/2019 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 206 312 51% 405 599 48% Gross Profit 138 201 46% 273 389 42% EBITDA 49 95 94% 99 186 88